Interview, Podcast
John Coogan, EIR at Founders Fund, Founder of Soylent & Lucy
- Anticipates launching a new company in 2016 to capitalize on an upcoming regulatory window before new laws create high barriers to entry, predicting a market evolution toward a monopolistic or oligopolistic structure.
- Foresees a regulatory landscape where FDA approval for new products may take five years or more, with venture capitalists facing similar wait times before sales begin and significant upfront capital requirements of tens to hundreds of millions of dollars.
- Projects the overall nicotine replacement therapy (NRT) market to remain under $1 billion in revenue, facing competition from low-cost generic alternatives like Nicorette, while Zyn is expected to become a primary growth driver.
- Plans to generate revenue during the lengthy regulatory wait period with slow growth, focusing storytelling efforts on retailers to demonstrate profitability rather than direct consumer marketing via podcasts due to nicotine discussion restrictions.
- Envisions a business model where monthly revenue roughly equals inventory, avoiding massive R&D expenses and future charging models, with sufficient profitability to forgo further fundraising even after a potential market crash.
- Predicts that the US government will delay definitive safety claims on vaping products due to Supreme Court rulings limiting FDA authority, though a shift in FDA leadership could alter the conversation around youth initiation.
- Expresses concern that rolling back the ban on menthol cigarettes and current political constraints on cigarettes will negatively impact public health, advocating for a regulatory tilt that imposes double the restrictions and taxes on cigarettes compared to other products.
- Maintains that competitors cannot claim products help with smoking cessation due to a lack of FDA study, while noting that current regulations create a level playing field that is too high for new entrants.
- Observes that venture capital has been "psyoped" into devaluing businesses without billion-dollar valuations, predicting a cultural shift where more entrepreneurs build profitable lifestyle businesses or niche AI gadgets rather than chasing VC funding.
- Predicts a future similar to the "Flappy Bird" phenomenon where young developers generate significant monthly revenue (e.g., $100,000) with niche AI applications, though moderate success stories in the AI sector may be rare due to economic constraints.
- Identifies specific consumer technology trends, including the expectation that children will embrace the Rabbit R1 device for learning prompt engineering and that a 18-year-old building a chat GPT app can accumulate capital to take further risks.
- Notes that new product development is hindered by the need for massive investment and long regulatory waits, while also expecting the company to challenge big tobacco firms which are perceived as poorly run with degraded quality.